The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Here’s What Happened at Probiota, 13-15 February in Copenhagen
Editor's Choice

Here’s What Happened at Probiota, 13-15 February in Copenhagen

MAR 1, 2019
Kaleido Biosciences Announces Pricing of Initial Public Offering
Finance

Kaleido Biosciences Announces Pricing of Initial Public Offering

MAR 1, 2019
Pivot Bio Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2019
Phytobiome & Environment

Pivot Bio Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2019

FEB 28, 2019
Axial Biotherapeutics Raises $25 Million in Series B Financing
Finance

Axial Biotherapeutics Raises $25 Million in Series B Financing

FEB 28, 2019
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Clinical & Manufacturing

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

FEB 28, 2019
KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc.
Finance

KNOW Bio Announces Creation of Digestive Health Therapeutics, Inc.

FEB 28, 2019
DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides
Finance

DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides

FEB 28, 2019
Evogene Announces Establishment of Ag-Biologicals Subsidiary – LaVie Bio Ltd.
Phytobiome & Environment

Evogene Announces Establishment of Ag-Biologicals Subsidiary – LaVie Bio Ltd.

FEB 26, 2019
New ‘interspecies communication’ strategy between gut bacteria and mammalian hosts uncovered
Animal Health

New ‘interspecies communication’ strategy between gut bacteria and mammalian hosts uncovered

FEB 22, 2019
BiomX Raises $32 Million in Series B Financing
Finance

BiomX Raises $32 Million in Series B Financing

FEB 20, 2019
S-Biomedic Completes Series A Round With DSM Venturing
Finance

S-Biomedic Completes Series A Round With DSM Venturing

FEB 18, 2019